Yasuko Shusa

Medical Device | Technology Assessment, CVC, Investor, Corporate Strategy, Global Business Development, R&D Collaboration

Venture Investment Lead - Olympus Innovation Ventures
2014 - 2022
Aug 2021 - Oct 2022 OLYMPUS INNOVATION VENTURES/OIV | CVC Group, A stage agnostic venture fund *FOCUS AREA: GI, Respiratory, Urology Apr 2019 - Aug 2021 OLYMPUS Corporation of The Americas | Global Business Development: Technology Exploration & Alliance | R&D/Innovation Strategy Global: Technology Scouting *FOCUS AREA: GI, Respiratory, Urology, AI, Robotics Apr 2015 - Mar 2019 OLYMPUS Communication Technology of America - A subsidiary of Olympus Corporation of the Americas: Primary responsible for establishing collaboration strategy by scouting innovative medical device technology. Research qualified companies for new partnership opportunities for Olympus's strategic fit in technology and market. Interacting with startups, VCs, Universities, R&D Institutions to initiate collaboration for joint development, licensing and M&A. 2014 - 2015 Worked as an exclusive consultant for Olympus HQ in Japan

Director, Strategic Business Development
2004 - 2013
A subsidiary of Olympus Corporation (Medical Systems, Scientific Solutions, and R&D) Formerly ITX International Holdings/Nissho Iwai (Corporate Venture Capital) * Researched qualified companies for new partnership and/or early-stage investment opportunities for strategic fit in technology and market. * Invested up to $5.0 million in several early stage companies, based on research, market, competitor analysis, and other investment criteria. Conducted thorough due diligence prior to negotiations. * Established and maintained strong ongoing relationships with venture capitalists, entrepreneurial scientists, top tier university professors for on-site analysis and assessment of prospective technologies, business models, financial health, and strategic planning in preparation for potential partnership or acquisition. * Led internal and external cross-functional teams to identify synergy, discuss potential business relationships, and nurture company growth through strategic business development.

Manager, Business Development
2002 - 2004
”SB Life Science Equity Management” Venture Capital firm founded by SoftBank, targeting the entire spectrum of Life Science: Medical Device, Biotechnology, incl. Pharmaceutical Development/Drug Discovery tools & platforms, and Medical informatics.

Director, Corporate Development
2000 - 2002
IT/MSP Start-Up Company, Spin off of Itochu Corporation